ReP USP - Resultado da busca

Artigo de periodico
Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways (2024)
Borges, Lara Gimenez; Alves, Thais Nascimento de Oliveira; Vassiliades, Sandra Valeria ; Parise Filho, Roberto
Source: Current Medicinal Chemistry. Unidades: FCF, IQ
Subjects: FÁRMACOS, ANALGÉSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Lara Gimenez et al. Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways. Current Medicinal Chemistry, 2024Tradução . . Disponível em: https://dx.doi.org/10.2174/0109298673310050240821054652. Acesso em: 13 nov. 2024.
APA
Borges, L. G., Alves, T. N. de O., Vassiliades, S. V., & Parise Filho, R. (2024). Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways. Current Medicinal Chemistry. doi:10.2174/0109298673310050240821054652
NLM
Borges LG, Alves TN de O, Vassiliades SV, Parise Filho R. Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways [Internet]. Current Medicinal Chemistry. 2024 ;[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.2174/0109298673310050240821054652
Vancouver
Borges LG, Alves TN de O, Vassiliades SV, Parise Filho R. Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways [Internet]. Current Medicinal Chemistry. 2024 ;[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.2174/0109298673310050240821054652
Artigo de periodico
Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments (2023)
Lirio, Adriana Cogo Malgueiro ; Diaz, Victor A. Febo; Chellappan, Dinesh Kumar ; Dua, Kamal ; Lourenço, Felipe Rebello ; Pinto, Terezinha de Jesus Andreoli
Source: Journal of Pharmaceutical Innovation. Unidade: FCF
Subjects: FÁRMACOS, MONITORAMENTO AMBIENTAL, CONTROLE DE PROCESSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIRIO, Adriana Cogo Malgueiro et al. Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments. Journal of Pharmaceutical Innovation, v. 18, p. 1362-1370, 2023Tradução . . Disponível em: https://doi.org/10.1007/s12247-023-09719-4. Acesso em: 13 nov. 2024.
APA
Lirio, A. C. M., Diaz, V. A. F., Chellappan, D. K., Dua, K., Lourenço, F. R., & Pinto, T. de J. A. (2023). Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments. Journal of Pharmaceutical Innovation, 18, 1362-1370. doi:10.1007/s12247-023-09719-4
NLM
Lirio ACM, Diaz VAF, Chellappan DK, Dua K, Lourenço FR, Pinto T de JA. Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments [Internet]. Journal of Pharmaceutical Innovation. 2023 ; 18 1362-1370.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s12247-023-09719-4
Vancouver
Lirio ACM, Diaz VAF, Chellappan DK, Dua K, Lourenço FR, Pinto T de JA. Development of a statistical approach for microbial monitoring in non‑sterile pharmaceutical environments [Internet]. Journal of Pharmaceutical Innovation. 2023 ; 18 1362-1370.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s12247-023-09719-4
Artigo de periodico
Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions (2023)
Yukuyama, Megumi Nishitani ; Zuo, Jieyu; Park, Chulhun; Yousef, Malaz ; Henostroza, Mirla Anali Bazan; Araujo, Gabriel Lima Barros de ; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar
Source: International Journal of Pharmaceutics. Unidade: FCF
Subjects: FÁRMACOS, ANTI-HELMÍNTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YUKUYAMA, Megumi Nishitani et al. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions. International Journal of Pharmaceutics, v. 632, p. 1-9 art. 122554, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2022.122554. Acesso em: 13 nov. 2024.
APA
Yukuyama, M. N., Zuo, J., Park, C., Yousef, M., Henostroza, M. A. B., Araujo, G. L. B. de, et al. (2023). Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions. International Journal of Pharmaceutics, 632, 1-9 art. 122554. doi:10.1016/j.ijpharm.2022.122554
NLM
Yukuyama MN, Zuo J, Park C, Yousef M, Henostroza MAB, Araujo GLB de, Bou-Chacra NA, Löbenberg R. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions [Internet]. International Journal of Pharmaceutics. 2023 ; 632 1-9 art. 122554.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122554
Vancouver
Yukuyama MN, Zuo J, Park C, Yousef M, Henostroza MAB, Araujo GLB de, Bou-Chacra NA, Löbenberg R. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions [Internet]. International Journal of Pharmaceutics. 2023 ; 632 1-9 art. 122554.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122554
Artigo de periodico
Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats (2023)
Souza, Aline de ; Almeida, Maria Karilly Lima de; Barbosa, João Antonio; Yukuyama, Megumi Nishitani ; Correia, Cristiano de Jesus; Faloppa, Ana Cristina Breithaupt ; Bou-Chacra, Nadia Araci ; Calixto, Leandro Augusto
Source: Chemistry Africa. Unidades: FM, FCF
Subjects: TRYPANOSOMA CRUZI, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Aline de et al. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats. Chemistry Africa, v. 6, p. 837-843, 2023Tradução . . Disponível em: https://doi.org/10.1007/s42250-022-00547-6. Acesso em: 13 nov. 2024.
APA
Souza, A. de, Almeida, M. K. L. de, Barbosa, J. A., Yukuyama, M. N., Correia, C. de J., Faloppa, A. C. B., et al. (2023). Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats. Chemistry Africa, 6, 837-843. doi:10.1007/s42250-022-00547-6
NLM
Souza A de, Almeida MKL de, Barbosa JA, Yukuyama MN, Correia C de J, Faloppa ACB, Bou-Chacra NA, Calixto LA. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats [Internet]. Chemistry Africa. 2023 ; 6 837-843.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s42250-022-00547-6
Vancouver
Souza A de, Almeida MKL de, Barbosa JA, Yukuyama MN, Correia C de J, Faloppa ACB, Bou-Chacra NA, Calixto LA. Development of an HPLC method for identification and quantification of anti-leishmaniasis drug candidate NFOH after oral administration of NLC-NFOH in rats [Internet]. Chemistry Africa. 2023 ; 6 837-843.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s42250-022-00547-6
Artigo de periodico
Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines (2023)
Caffaro, Arthur Massabki; Lourenço, Felipe Rebello
Source: Chemometrics and Intelligent Laboratory Systems. Unidade: FCF
Assunto: FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAFFARO, Arthur Massabki e LOURENÇO, Felipe Rebello. Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines. Chemometrics and Intelligent Laboratory Systems, v. 241, p. 1-9 art. 104935, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.chemolab.2023.104935. Acesso em: 13 nov. 2024.
APA
Caffaro, A. M., & Lourenço, F. R. (2023). Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines. Chemometrics and Intelligent Laboratory Systems, 241, 1-9 art. 104935. doi:10.1016/j.chemolab.2023.104935
NLM
Caffaro AM, Lourenço FR. Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines [Internet]. Chemometrics and Intelligent Laboratory Systems. 2023 ; 241 1-9 art. 104935.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.chemolab.2023.104935
Vancouver
Caffaro AM, Lourenço FR. Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines [Internet]. Chemometrics and Intelligent Laboratory Systems. 2023 ; 241 1-9 art. 104935.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.chemolab.2023.104935
Artigo de periodico
Absorption matters: a closer look at popular oral bioavailability rules for drug approvals (2023)
Trossini, Gustavo Henrique Goulart ; Soares, Artur Caminero Gomes; Sousa, Gustavo Henrique Marques; Calil, Raisa Ludmila
Source: Molecular informatics. Unidade: FCF
Subjects: FÁRMACOS, ABSORÇÃO, BIODISPONIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TROSSINI, Gustavo Henrique Goulart et al. Absorption matters: a closer look at popular oral bioavailability rules for drug approvals. Molecular informatics, v. 42, n. 11, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.1002/minf.202300115. Acesso em: 13 nov. 2024.
APA
Trossini, G. H. G., Soares, A. C. G., Sousa, G. H. M., & Calil, R. L. (2023). Absorption matters: a closer look at popular oral bioavailability rules for drug approvals. Molecular informatics, 42( 11), 1-12. doi:10.1002/minf.202300115
NLM
Trossini GHG, Soares ACG, Sousa GHM, Calil RL. Absorption matters: a closer look at popular oral bioavailability rules for drug approvals [Internet]. Molecular informatics. 2023 ; 42( 11): 1-12.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/minf.202300115
Vancouver
Trossini GHG, Soares ACG, Sousa GHM, Calil RL. Absorption matters: a closer look at popular oral bioavailability rules for drug approvals [Internet]. Molecular informatics. 2023 ; 42( 11): 1-12.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/minf.202300115
Artigo de periodico
Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years (2023)
Vassiliades, Sandra Valeria ; Navarausckas, Vitor Bastos; Dias, Marcio Vinicius Bertacine ; Parise Filho, Roberto
Source: Biointerface Research in Applied Chemistry. Unidades: ICB, FCF
Subjects: TUBERCULOSE, FÁRMACOS, MYCOBACTERIUM TUBERCULOSIS, MICROBIOLOGIA, ANTIBIÓTICOS, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VASSILIADES, Sandra Valeria et al. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years. Biointerface Research in Applied Chemistry, v. 13, n. 1 p. 1-20 art. 79, 2023Tradução . . Disponível em: https://doi.org/10.33263/BRIAC131.079. Acesso em: 13 nov. 2024.
APA
Vassiliades, S. V., Navarausckas, V. B., Dias, M. V. B., & Parise Filho, R. (2023). Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years. Biointerface Research in Applied Chemistry, 13( 1 p. 1-20 art. 79). doi:10.33263/BRIAC131.079
NLM
Vassiliades SV, Navarausckas VB, Dias MVB, Parise Filho R. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years [Internet]. Biointerface Research in Applied Chemistry. 2023 ; 13( 1 p. 1-20 art. 79):[citado 2024 nov. 13 ] Available from: https://doi.org/10.33263/BRIAC131.079
Vancouver
Vassiliades SV, Navarausckas VB, Dias MVB, Parise Filho R. Mycobacterium tuberculosis dihydrofolate reductase inhibitors: State of Art Past 20 Years [Internet]. Biointerface Research in Applied Chemistry. 2023 ; 13( 1 p. 1-20 art. 79):[citado 2024 nov. 13 ] Available from: https://doi.org/10.33263/BRIAC131.079
Trabalho de evento-resumo periodico
Effect of grinding procedures on the ritonavir-lopinavir system (2022)
Pinheiro, L. B. M; Culbertson, Elizabeth; Araujo, Gabriel Lima Barros de ; Billinge, Simon; Ferreira, Fabio Furlan
Source: Acta Crystallographica Section A. Conference titles: Congress and General Assembly of the International Union of Crystallography/IUCr. Unidade: FCF
Subjects: FÁRMACOS, HIV
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINHEIRO, L. B. M et al. Effect of grinding procedures on the ritonavir-lopinavir system. Acta Crystallographica Section A. Hoboken: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://scripts.iucr.org/cgi-bin/paper?S0108767321088164. Acesso em: 13 nov. 2024. , 2022
APA
Pinheiro, L. B. M., Culbertson, E., Araujo, G. L. B. de, Billinge, S., & Ferreira, F. F. (2022). Effect of grinding procedures on the ritonavir-lopinavir system. Acta Crystallographica Section A. Hoboken: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de https://scripts.iucr.org/cgi-bin/paper?S0108767321088164
NLM
Pinheiro LBM, Culbertson E, Araujo GLB de, Billinge S, Ferreira FF. Effect of grinding procedures on the ritonavir-lopinavir system [Internet]. Acta Crystallographica Section A. 2022 ; A77 C882 res. PS-19-6.[citado 2024 nov. 13 ] Available from: https://scripts.iucr.org/cgi-bin/paper?S0108767321088164
Vancouver
Pinheiro LBM, Culbertson E, Araujo GLB de, Billinge S, Ferreira FF. Effect of grinding procedures on the ritonavir-lopinavir system [Internet]. Acta Crystallographica Section A. 2022 ; A77 C882 res. PS-19-6.[citado 2024 nov. 13 ] Available from: https://scripts.iucr.org/cgi-bin/paper?S0108767321088164
Artigo de periodico
Describing the influence of ball-milling on the amorphization of flubendazole using the PDF and RMC methods with X-ray powder diffraction data (2022)
Bezzon, Vinícius Danilo Nonato ; Pinto, Rogério da Silva; Araujo, Gabriel Lima Barros de ; Lima, João Cardoso de ; Ferreira, Fábio Furlan
Source: Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: FÁRMACOS, MÉTODO DE MONTE CARLO, BIODISPONIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BEZZON, Vinícius Danilo Nonato et al. Describing the influence of ball-milling on the amorphization of flubendazole using the PDF and RMC methods with X-ray powder diffraction data. Journal of Pharmaceutical Sciences, v. 111, n. 11, p. 3054-3063, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.xphs.2022.06.018. Acesso em: 13 nov. 2024.
APA
Bezzon, V. D. N., Pinto, R. da S., Araujo, G. L. B. de, Lima, J. C. de, & Ferreira, F. F. (2022). Describing the influence of ball-milling on the amorphization of flubendazole using the PDF and RMC methods with X-ray powder diffraction data. Journal of Pharmaceutical Sciences, 111( 11), 3054-3063. doi:10.1016/j.xphs.2022.06.018
NLM
Bezzon VDN, Pinto R da S, Araujo GLB de, Lima JC de, Ferreira FF. Describing the influence of ball-milling on the amorphization of flubendazole using the PDF and RMC methods with X-ray powder diffraction data [Internet]. Journal of Pharmaceutical Sciences. 2022 ; 111( 11): 3054-3063.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.xphs.2022.06.018
Vancouver
Bezzon VDN, Pinto R da S, Araujo GLB de, Lima JC de, Ferreira FF. Describing the influence of ball-milling on the amorphization of flubendazole using the PDF and RMC methods with X-ray powder diffraction data [Internet]. Journal of Pharmaceutical Sciences. 2022 ; 111( 11): 3054-3063.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.xphs.2022.06.018
Artigo de periodico
In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium (2022)
Hajjar, Braa; Zuo, Jieyu; Park, Chulhun; Azarmi, Shirzad; Silva, Daniela Amaral; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar
Source: AAPS PharmSciTech. Unidade: FCF
Subjects: ANTI-INFLAMATÓRIOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HAJJAR, Braa et al. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium. AAPS PharmSciTech, v. 23, p. 1-9 art. 102, 2022Tradução . . Disponível em: https://doi.org/10.1208/s12249-022-02258-0. Acesso em: 13 nov. 2024.
APA
Hajjar, B., Zuo, J., Park, C., Azarmi, S., Silva, D. A., Bou-Chacra, N. A., & Löbenberg, R. (2022). In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium. AAPS PharmSciTech, 23, 1-9 art. 102. doi:10.1208/s12249-022-02258-0
NLM
Hajjar B, Zuo J, Park C, Azarmi S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium [Internet]. AAPS PharmSciTech. 2022 ; 23 1-9 art. 102.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1208/s12249-022-02258-0
Vancouver
Hajjar B, Zuo J, Park C, Azarmi S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium [Internet]. AAPS PharmSciTech. 2022 ; 23 1-9 art. 102.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1208/s12249-022-02258-0
Artigo de periodico
Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development (2022)
Yousef, Malaz ; Park, Chulhun; Le, Tyson S; Bou-Chacra, Nadia Araci ; Davies, Neal M; Löbenberg, Raimar
Source: Dissolutiom Technologies. Unidade: FCF
Subjects: FÁRMACOS, SISTEMA LINFÁTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOUSEF, Malaz et al. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development. Dissolutiom Technologies, v. 29, n. 2, p. 86-93, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P86. Acesso em: 13 nov. 2024.
APA
Yousef, M., Park, C., Le, T. S., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2022). Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development. Dissolutiom Technologies, 29( 2), 86-93. doi:10.14227/DT290222P86
NLM
Yousef M, Park C, Le TS, Bou-Chacra NA, Davies NM, Löbenberg R. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development [Internet]. Dissolutiom Technologies. 2022 ; 29( 2): 86-93.[citado 2024 nov. 13 ] Available from: https://doi.org/10.14227/DT290222P86
Vancouver
Yousef M, Park C, Le TS, Bou-Chacra NA, Davies NM, Löbenberg R. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development [Internet]. Dissolutiom Technologies. 2022 ; 29( 2): 86-93.[citado 2024 nov. 13 ] Available from: https://doi.org/10.14227/DT290222P86
Patente
Preparação e uso de nanocristais de dapsona para tratamento de múltiplas doenças (2022)
Bou-Chacra, Nadia Araci ; Rocha, Nataly Paredes da
Unidade: FCF
Subjects: FÁRMACOS, DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOU-CHACRA, Nadia Araci e ROCHA, Nataly Paredes da. Preparação e uso de nanocristais de dapsona para tratamento de múltiplas doenças. . São Paulo: Agência USP de Inovação/AUSPIN. Disponível em: http://patentes.usp.br/tech?title=PREPARA%c3%87%c3%83O_E_USO_DE_NANOCRISTAIS_DE_DAPSONA_PARA_TRATAMENTO_DE_M%c3%9aLTIPLAS_DOEN%c3%87AS. Acesso em: 13 nov. 2024. , 2022
APA
Bou-Chacra, N. A., & Rocha, N. P. da. (2022). Preparação e uso de nanocristais de dapsona para tratamento de múltiplas doenças. São Paulo: Agência USP de Inovação/AUSPIN. Recuperado de http://patentes.usp.br/tech?title=PREPARA%c3%87%c3%83O_E_USO_DE_NANOCRISTAIS_DE_DAPSONA_PARA_TRATAMENTO_DE_M%c3%9aLTIPLAS_DOEN%c3%87AS
NLM
Bou-Chacra NA, Rocha NP da. Preparação e uso de nanocristais de dapsona para tratamento de múltiplas doenças [Internet]. 2022 ;[citado 2024 nov. 13 ] Available from: http://patentes.usp.br/tech?title=PREPARA%c3%87%c3%83O_E_USO_DE_NANOCRISTAIS_DE_DAPSONA_PARA_TRATAMENTO_DE_M%c3%9aLTIPLAS_DOEN%c3%87AS
Vancouver
Bou-Chacra NA, Rocha NP da. Preparação e uso de nanocristais de dapsona para tratamento de múltiplas doenças [Internet]. 2022 ;[citado 2024 nov. 13 ] Available from: http://patentes.usp.br/tech?title=PREPARA%c3%87%c3%83O_E_USO_DE_NANOCRISTAIS_DE_DAPSONA_PARA_TRATAMENTO_DE_M%c3%9aLTIPLAS_DOEN%c3%87AS
Artigo de jornal-dep/entr
Pesquisadores testam nova estratégia para acelerar o desenvolvimento de fármacos [Depoimento a Maria Fernanda Ziegler] (2022)
Araujo, Gabriel Lima Barros de
Source: Agência FAPESP. Unidade: FCF
Subjects: FÁRMACOS, RADIAÇÃO SINCROTRON, DISPERSÃO DA LUZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Gabriel Lima Barros de. Pesquisadores testam nova estratégia para acelerar o desenvolvimento de fármacos [Depoimento a Maria Fernanda Ziegler]. Agência FAPESP. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://agencia.fapesp.br/pesquisadores-testam-nova-estrategia-para-acelerar-o-desenvolvimento-de-farmacos/37878/#:~:text=*E2*80*9CExiste%um%grande%investimento%do,de%Farm*C3*A1cia%da%FCF*2DUSP. Acesso em: 13 nov. 2024. , 2022
APA
Araujo, G. L. B. de. (2022). Pesquisadores testam nova estratégia para acelerar o desenvolvimento de fármacos [Depoimento a Maria Fernanda Ziegler]. Agência FAPESP. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de https://agencia.fapesp.br/pesquisadores-testam-nova-estrategia-para-acelerar-o-desenvolvimento-de-farmacos/37878/#:~:text=*E2*80*9CExiste%um%grande%investimento%do,de%Farm*C3*A1cia%da%FCF*2DUSP.
NLM
Araujo GLB de. Pesquisadores testam nova estratégia para acelerar o desenvolvimento de fármacos [Depoimento a Maria Fernanda Ziegler] [Internet]. Agência FAPESP. 2022 ;08 fe 2022. on-line[citado 2024 nov. 13 ] Available from: https://agencia.fapesp.br/pesquisadores-testam-nova-estrategia-para-acelerar-o-desenvolvimento-de-farmacos/37878/#:~:text=*E2*80*9CExiste%um%grande%investimento%do,de%Farm*C3*A1cia%da%FCF*2DUSP.
Vancouver
Araujo GLB de. Pesquisadores testam nova estratégia para acelerar o desenvolvimento de fármacos [Depoimento a Maria Fernanda Ziegler] [Internet]. Agência FAPESP. 2022 ;08 fe 2022. on-line[citado 2024 nov. 13 ] Available from: https://agencia.fapesp.br/pesquisadores-testam-nova-estrategia-para-acelerar-o-desenvolvimento-de-farmacos/37878/#:~:text=*E2*80*9CExiste%um%grande%investimento%do,de%Farm*C3*A1cia%da%FCF*2DUSP.
Trabalho de evento
In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium (2022)
Hajjar, Braa; Zuo, Jieyu ; Azami, Shirzad; Silva, Daniela Amaral ; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar
Source: Abstracts. Conference titles: Research Day Equity in Health and Research. Unidade: FCF
Assunto: FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HAJJAR, Braa et al. In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium. 2022, Anais.. Alberta: University of Alberta, 2022. Disponível em: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf. Acesso em: 13 nov. 2024.
APA
Hajjar, B., Zuo, J., Azami, S., Silva, D. A., Bou-Chacra, N. A., & Löbenberg, R. (2022). In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium. In Abstracts. Alberta: University of Alberta. Recuperado de https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf
NLM
Hajjar B, Zuo J, Azami S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium [Internet]. Abstracts. 2022 ;[citado 2024 nov. 13 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf
Vancouver
Hajjar B, Zuo J, Azami S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro study of a foamable microemulsion for improved topical delivery of diclofenac sodium [Internet]. Abstracts. 2022 ;[citado 2024 nov. 13 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Zuo-poster.pdf
Trabalho de evento
In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons (2022)
Yousef, Malaz ; Bou-Chacra, Nadia Araci ; Davies, Neal M; Löbenberg, Raimar
Source: Abstracts. Conference titles: Research Day Equity in Health and Research. Unidade: FCF
Subjects: FÁRMACOS, XENOBIÓTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOUSEF, Malaz et al. In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons. 2022, Anais.. Alberta: University of Alberta, 2022. Disponível em: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Malaz-Yousef.pdf. Acesso em: 13 nov. 2024.
APA
Yousef, M., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2022). In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons. In Abstracts. Alberta: University of Alberta. Recuperado de https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Malaz-Yousef.pdf
NLM
Yousef M, Bou-Chacra NA, Davies NM, Löbenberg R. In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons [Internet]. Abstracts. 2022 ;[citado 2024 nov. 13 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Malaz-Yousef.pdf
Vancouver
Yousef M, Bou-Chacra NA, Davies NM, Löbenberg R. In-vitro model to forecast the lymphatic uptake/inhibition of drugs via chylomicrons [Internet]. Abstracts. 2022 ;[citado 2024 nov. 13 ] Available from: https://www.cspscanada.org/wp-content/uploads/CSPS-2022-Malaz-Yousef.pdf
Trabalho de evento-resumo
Adverse drug events in an intensive care unit: a pilot study using the global trigger tool (2022)
Souza, R. N. D; Moriel, Patricia ; Ventura, Deise de Souza; Perroud Junior, Mauricio Wesley ; Visacri, Marilia Berlofa
Source: Abstracts. Conference titles: ISoP Annual Meeting "A New Era of Pharmacovigilance: Challenges and Opportunities". Unidade: FCF
Subjects: FÁRMACOS, FARMACOVIGILÂNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, R. N. D et al. Adverse drug events in an intensive care unit: a pilot study using the global trigger tool. 2022, Anais.. London: International Society of Pharmacovigilance/ISOP, 2022. . Acesso em: 13 nov. 2024.
APA
Souza, R. N. D., Moriel, P., Ventura, D. de S., Perroud Junior, M. W., & Visacri, M. B. (2022). Adverse drug events in an intensive care unit: a pilot study using the global trigger tool. In Abstracts. London: International Society of Pharmacovigilance/ISOP.
NLM
Souza RND, Moriel P, Ventura D de S, Perroud Junior MW, Visacri MB. Adverse drug events in an intensive care unit: a pilot study using the global trigger tool. Abstracts. 2022 ;[citado 2024 nov. 13 ]
Vancouver
Souza RND, Moriel P, Ventura D de S, Perroud Junior MW, Visacri MB. Adverse drug events in an intensive care unit: a pilot study using the global trigger tool. Abstracts. 2022 ;[citado 2024 nov. 13 ]
Artigo de periodico
Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test (2022)
Chauca, Enma Perez ; Plasencia, Pedro M. Alva ; Ferraz, Humberto Gomes
Source: Journal of Pharmacy and Pharmacognosy Research. Unidade: FCF
Subjects: ESPECTROFOTOMETRIA, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAUCA, Enma Perez e PLASENCIA, Pedro M. Alva e FERRAZ, Humberto Gomes. Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test. Journal of Pharmacy and Pharmacognosy Research, v. 10, n. 5, p. 847-856, 2022Tradução . . Disponível em: https://doi.org/10.56499/jppres22.1433_10.5.847. Acesso em: 13 nov. 2024.
APA
Chauca, E. P., Plasencia, P. M. A., & Ferraz, H. G. (2022). Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test. Journal of Pharmacy and Pharmacognosy Research, 10( 5), 847-856. doi:10.56499/jppres22.1433_10.5.847
NLM
Chauca EP, Plasencia PMA, Ferraz HG. Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2022 ; 10( 5): 847-856.[citado 2024 nov. 13 ] Available from: https://doi.org/10.56499/jppres22.1433_10.5.847
Vancouver
Chauca EP, Plasencia PMA, Ferraz HG. Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2022 ; 10( 5): 847-856.[citado 2024 nov. 13 ] Available from: https://doi.org/10.56499/jppres22.1433_10.5.847
Artigo de periodico
Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review (2022)
Reyes, Pia Loren ; Saavedra, Nicolás ; Torso, Nadine de Godoy ; Visacri, Marilia Berlofa ; Moriel, Patricia ; Salazar, Luis Antônio
Source: Frontiers in Pharmacology. Unidade: FCF
Subjects: FÁRMACOS, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REYES, Pia Loren et al. Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review. Frontiers in Pharmacology, v. 13, p. 1-19, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.831099. Acesso em: 13 nov. 2024.
APA
Reyes, P. L., Saavedra, N., Torso, N. de G., Visacri, M. B., Moriel, P., & Salazar, L. A. (2022). Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review. Frontiers in Pharmacology, 13, 1-19. doi:10.3389/fphar.2022.831099
NLM
Reyes PL, Saavedra N, Torso N de G, Visacri MB, Moriel P, Salazar LA. Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-19.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/fphar.2022.831099
Vancouver
Reyes PL, Saavedra N, Torso N de G, Visacri MB, Moriel P, Salazar LA. Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-19.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/fphar.2022.831099
Artigo de periodico
Insights into newly approved drugs from a medicinal chemistry perspective (2021)
Lima, Elys Juliane Cardoso ; Gomes, Renan Augusto ; Fornari, Evelin; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Source: Mini-Reviews in Medicinal Chemistry. Unidades: FCFRP, FCF
Assunto: FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Elys Juliane Cardoso et al. Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, v. 21, n. 16, p. 2227-2248, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389557521666210226145328. Acesso em: 13 nov. 2024.
APA
Lima, E. J. C., Gomes, R. A., Fornari, E., Emery, F. da S., & Trossini, G. H. G. (2021). Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, 21( 16), 2227-2248. doi:10.2174/1389557521666210226145328
NLM
Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1389557521666210226145328
Vancouver
Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1389557521666210226145328
Apresentacao sonora/cenica/entrevista
Estudo de fármacos contra covid-19 deve levar em conta eficácia e segurança (2021)
Trossini, Gustavo Henrique Goulart ; Lopes, Norberto Peporine
Source: Jornal da USP. Unidades: FCF, FCFRP
Subjects: FÁRMACOS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TROSSINI, Gustavo Henrique Goulart e LOPES, Norberto Peporine. Estudo de fármacos contra covid-19 deve levar em conta eficácia e segurança. Jornal da USP. São Paulo: Universidade de São Paulo - USP. Disponível em: https://jornal.usp.br/podcast/momento-tecnologia-47-estudo-de-farmacos-contra-covid-19-deve-levar-em-conta-eficacia-e-seguranca. Acesso em: 13 nov. 2024. , 2021
APA
Trossini, G. H. G., & Lopes, N. P. (2021). Estudo de fármacos contra covid-19 deve levar em conta eficácia e segurança. Jornal da USP. São Paulo: Universidade de São Paulo - USP. Recuperado de https://jornal.usp.br/podcast/momento-tecnologia-47-estudo-de-farmacos-contra-covid-19-deve-levar-em-conta-eficacia-e-seguranca
NLM
Trossini GHG, Lopes NP. Estudo de fármacos contra covid-19 deve levar em conta eficácia e segurança [Internet]. Jornal da USP. 2021 ;[citado 2024 nov. 13 ] Available from: https://jornal.usp.br/podcast/momento-tecnologia-47-estudo-de-farmacos-contra-covid-19-deve-levar-em-conta-eficacia-e-seguranca
Vancouver
Trossini GHG, Lopes NP. Estudo de fármacos contra covid-19 deve levar em conta eficácia e segurança [Internet]. Jornal da USP. 2021 ;[citado 2024 nov. 13 ] Available from: https://jornal.usp.br/podcast/momento-tecnologia-47-estudo-de-farmacos-contra-covid-19-deve-levar-em-conta-eficacia-e-seguranca

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Grupo de pesquisa

Funding Agencies

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration